TAG: "Administration"

UCSF Mission Bay hospital complex to open Feb. 1

Three new hospitals for women, children and cancer patients.

UCSF Medical Center at Mission Bay will open Feb. 1, 2015. (Photo by Mark Citret)

After more than 10 years of planning and construction, UCSF Medical Center at Mission Bay will open Feb. 1, 2015 on UC San Francisco’s world-renowned biomedical research campus. UCSF Medical Center at Mission Bay comprises UCSF Benioff Children’s Hospital San Francisco, UCSF Betty Irene Moore Women’s Hospital and UCSF Bakar Cancer Hospital. The new facilities include a 289-bed hospital complex, with children’s emergency and outpatient services that will integrate research and medical advancements with patient-focused, compassionate care.​

UCSF Medical Center at Mission Bay will welcome its first patients the morning of Feb. 1, when teams of health care professionals and ambulances begin moving some inpatients from the UCSF Parnassus campus and Mount Zion campus into the new facilities.

The new medical center, strategically located on UCSF’s 60.2-acre Mission Bay research campus, will enhance UCSF’s ecosystem of innovation by putting physicians in close proximity to researchers and near biotechnology and pharmaceutical companies in Mission Bay and beyond. The new cancer hospital, for example, will sit near the UCSF Helen Diller Family Cancer Research Building, where every day leading scientists are seeking causes and cures for cancer.

UCSF Medical Center at Mission Bay also will feature the only operating hospital helipad in San Francisco to transport critically ill babies, children and pregnant women to the medical center from outlying hospitals.

“UCSF Medical Center at Mission Bay profoundly advances our ability to fulfill our mission as a public hospital, providing high-quality health care that meets the future needs of the entire Bay Area,” said Mark R. Laret, CEO, UCSF Medical Center and UCSF Benioff Children’s Hospitals. “By embedding clinical care within our research enterprise at Mission Bay, UCSF physicians and scientists in the forefront of cancer medicine, and women’s and children’s health will be able to more readily translate discoveries into next-generation therapies and cures.”

Each of the new hospitals’ designs reflects significant input from patients and families, as well as clinicians.

“UCSF Medical Center at Mission Bay sets a national benchmark for patient- and family-centered health care by offering an unparalleled healing environment that supports and connects patients and their families during hospital stays,” said Cindy Lima, executive director, UCSF Mission Bay Hospitals Project. “These new hospitals expand our capacity to provide the most advanced treatments in buildings that reflect input from the people who will use them.”

The hospitals feature state-of-the art technology, including the world’s largest hospital fleet of autonomous robotic couriers which will deliver linens, meals and medications. Interactive media walls in each private room will enable patients to communicate with their families and clinicians, and an imaging suite specially designed to eliminate anxiety during an MRI offers children the chance to virtually experience a San Francisco trolley ride, or to play with a cast of animated critters as they boat around the San Francisco Bay.

Distinctive features of UCSF Medical Center at Mission Bay include 4.3 acres of green space and 1.2 acres of rooftop gardens, soothing art- and light-filled interiors and a public plaza created in partnership with the City of San Francisco. In addition, UCSF Medical Center at Mission Bay is on target to be one of the first LEED Gold-certified hospital in California.

The Integrated Center for Design and Construction brought together more than 200 architects, engineers and contractors working side by side in a command center on the construction site. Construction of the hospitals began in December 2010.

“The healing power of UCSF Medical Center at Mission Bay extends beyond the hospitals’ walls, as clinicians and researchers work side by side to accelerate medical breakthroughs and transform the delivery of health care in this country,” said Sam Hawgood, M.B.B.S., chancellor of UC San Francisco. “It’s important to note that the hospital complex was built only through the generous philanthropic support of the Bay Area community, who share our vision of advancing health care across the world. We are greatly appreciative of their unwavering commitment to our mission over the past decade. ”

UCSF Benioff Children’s Hospital San Francisco

UCSF Benioff Children’s Hospital San Francisco, one of the nation’s leading children’s hospitals, provides treatment for virtually all pediatric conditions, as well as for critically ill newborns. The Neonatal Intensive Care Nursery at UCSF Benioff Children’s Hospital San Francisco was one of the first of its kind in the world. The hospital is the only California state-designated children’s medical center in San Francisco and is affiliated with UCSF Benioff Children’s Hospital Oakland.

The new 183-bed facility at Mission Bay creates an environment where children and their families find quality care at the forefront of scientific discovery. Private rooms in the intensive care nursery support the youngest patients, while the fully accredited classroom and teachers enable school-age patients to continue their education while focusing on their health. The hospital offers accommodations for families of pediatric patients and nearby lodging for those requiring longer stays.

UCSF Bakar Cancer Hospital

UCSF ranks consistently among the top cancer care centers in the nation, according to the “America’s Best Hospitals” survey from U.S. News & World Report. UCSF Bakar Cancer Hospital sets the standard in personalized care, delivering advanced cancer therapies tailored to individual patient needs. The hospital increases UCSF’s inpatient and outpatient capacity to meet growing demand, in a state-of-the-art facility. The new hospital will absorb many of the cancer surgery beds currently located at UCSF Medical Center at Mount Zion, offering cancer surgeries in specialties ranging from urology and orthopedics, to head and neck and gynecologic oncology. Specialists also serve the individual needs of cancer patients from the children’s and women’s hospitals. In the future, Mission Bay could house as many as 250 or more surgery beds, with a full complement of outpatient cancer care services.

UCSF Betty Irene Moore Women’s Hospital

As the region’s first dedicated women’s hospital, UCSF Betty Irene Moore Women’s Hospital will embody the philosophy of the UCSF National Center of Excellence in Women’s Health. The new hospital will deliver care that addresses health needs across a woman’s lifetime, including cancer treatment, specialty surgery, a 36-bed birth center, nine deluxe labor and delivery rooms, and select outpatient services. Customizing care to each patient, the hospital will provide the best available diagnostic tests and treatments in a caring, women- and family-focused environment that incorporates the latest technology. Spacious rooms allow loved ones to spend the day or night comfortably.

Each labor and delivery room is designed to be respectful to patients and families during the life-altering event of childbirth. Combining sophisticated technical capabilities with carefully considered design choices, each room emits a sense of calm for the birthing experience. At the same time, it is a highly functional space for clinicians to provide quality care.

View original article

Related link:
View press kit for additional information and multimedia materials

CATEGORY: NewsComments Off

UC Irvine Health announces affiliation with Corona Regional Medical Center

Priorities include enhancing cancer, stroke and perinatal-neonatal care.

UC Irvine Health and Corona Regional Medical Center announced a comprehensive affiliation that will enhance the depth and variety of specialty health care services available in Corona and nearby communities. A major hospital expansion project will accompany this affiliation.

“Our goal is to transform health care in west Riverside County,” said Mark Uffer, CEO and managing director of Corona Regional Medical Center. “The affiliation with UC Irvine Health complements our strengths, brings residents a variety of clinical services normally available only from an academic medical center and allows local patients to be treated closer to home.”

This transformation of Corona Regional Medical Center includes recently approved expansion plans that include an entirely new building. This new building will include a larger emergency room that more than doubles the size of the existing space and creates shelled space above that will be designed for future private patient rooms.

Corona Regional is a subsidiary of Universal Health Services Inc. The expansion and an affiliation with a prestigious university health system reflects the strong commitment UHS has toward meeting the needs of the growing communities along the Interstate 15 and Highway 91 corridors, Uffer said.

“We are pleased to provide the residents of the Inland Empire access to the clinical expertise we’re known for as an academic medical center,” said Terry A. Belmont, CEO of UC Irvine Medical Center. “The area is growing and it is a privilege to formalize the longstanding relationship we have with Corona Regional and the area’s residents.”

The agreement will initially focus on developing several key specialty services supported by UC Irvine’s clinical and research expertise:

  • Stroke telemedicine — Minutes count when treating a stroke. Backing up Corona Regional’s stroke program with the resources of UC Irvine Health and its Joint Commission-certified Comprehensive Stroke Center gives the community instant access to the region’s greatest concentration of fellowship-trained stroke neurologists and surgeons.
  • Cancer services — The two institutions will explore ways to bring the resources of UC Irvine Health’s National Cancer Institute-designated comprehensive cancer center to the Inland Empire. The UC Irvine Health Chao Family Comprehensive Cancer Center is one of only 41 in the United States and is dedicated to excellence in cancer treatment, prevention, research and education. Its specialists in medical and surgical oncology offer access to more than 150 ongoing clinical trials that reflect the latest cancer treatments.
  • Maternal-fetal medicine — The affiliation includes plans to create a perinatal services program in Corona, building on Corona Regional’s obstetrical and gynecological program and UC Irvine Health’s expertise in managing complex and high-risk pregnancies. This agreement formalizes a years-long relationship in which UC Irvine’s medical faculty assisted physicians at Corona Regional to manage difficult pregnancies and deliveries through the resources of the UC Irvine Health high-risk perinatal and regional neonatal intensive care services. The two organizations will also explore jointly developing a neonatal ICU at Corona Regional.

This affiliation is a natural extension of a longstanding connection between the greater Corona area and UC Irvine Medical Center. Many residents have roots in and commute to work in Orange County. UC Irvine Health has provided services to Corona-area residents for decades, including more than 525 last year who required tertiary care such as complex neurosurgery, high-risk perinatal, trauma and cancer services. This agreement strengthens the continuity of care for Corona Regional patients who need primary, specialty and tertiary services, as well as access to new health care resources.

Corona officials are enthusiastic about the announcement.

“I am elated that the expansion is finally coming to fruition, as the residents of Corona will benefit from more modern facilities and higher levels of care,” said Corona Mayor Karen Spiegel. A longtime supporter, Spiegel has worked closely with the Corona Regional administration for a decade on expansion plans. “We have worked hard to change the face of our city and to create a healthier community — one that we can all be proud of.”

Spiegel said the project will bring much needed health care services to the growing community and views the academic and clinical affiliation with UC Irvine Health as a major contribution to the quality of life for Inland Empire residents.

View original article

CATEGORY: NewsComments Off

UC San Diego names associate dean for public health

Bess Marcus to develop a Public Health Institute.

Bess Marcus, UC San Diego

Bess Marcus, Ph.D., has been appointed senior associate dean for public health with the UC San Diego School of Medicine. This new appointment recognizes the rapidly growing field of public health in academic medicine and its pivotal role in protecting and improving the health of individuals and communities through promotion of healthy lifestyles, research for disease and injury prevention, detection and control of infectious diseases and assessing hazardous environments.

Marcus will develop a Public Health Institute to serve as a home for all public health-oriented efforts at UC San Diego. This strategic role is designed to promote public health research and education activities across the campus, foster interdisciplinary conversations and collaborations, focus the need for resources and oversee public health degree offerings at UC San Diego.

“The ultimate goal of this new role and the institute is to help people achieve healthier, happier lives,” said Marcus who also serves as chair of the Department of Family and Preventive Medicine. “The university wants its passionate and talented public health students to serve in the broader community where, mentored by our top-notch research faculty, they can help to implement evidence-based health promotion and disease prevention programs.”

“The field of public health is central to addressing some of the most pressing health issues we face today, such as rising health care costs and the need for greater prevention of disease and disability across the lifespan,” said David Brenner, M.D., vice chancellor for UC San Diego Health Sciences and dean of the School of Medicine. “We are fortunate to have Dr. Marcus in this leadership role and look forward to developing programs that will impact the health of our local communities.”

Marcus earned her M.S. and PhD. degrees in clinical psychology from Auburn University, with a fellowship in behavioral medicine at Brown University.  She has published more than 200 peer-reviewed articles and three books. Her colleagues have recognized her with numerous awards, including the “Women Who Mean Business” Award from the San Diego Business Journal and the UC San Diego Equal Opportunity/Affirmative Action and Diversity Award.

For more than 25 years, Marcus has had continuous funding from the National Institutes of Health to conduct research aimed at promoting exercise adherence and understanding the acquisition and maintenance of exercise behavior. She developed and validated assessments for understanding the stages and processes of exercise behavior change and has also developed interventions to promote moderate-intensity physical activity in community, workplace and primary care settings. Over the past 10 years her research has focused on increasing physical activity among underserved and vulnerable populations.

She has regularly participated in American Heart Association, American College of Sports Medicine, Centers for Disease Control and Prevention, and National Institutes of Health panels, which have created recommendations and guidelines on the quantity and intensity of physical activity necessary for health benefits. She served on the Executive Committee for the Development of a National Strategic Plan for Physical Activity and she now serves on the Board of Directors for the National Physical Activity Plan Alliance.

View original article

CATEGORY: NewsComments Off

UC San Diego names CEO for faculty practice

Thomas Moore also will be dean of clinical affairs.

Thomas Moore, UC San Diego

Thomas Moore, M.D., has been named dean of clinical affairs and CEO for faculty practice at UC San Diego Health Sciences.

In this role, Moore will provide leadership of UC San Diego Medical Group as chair of the Board of Governors and will work closely with Health Sciences clinical department chairs and chief administrative officers to implement strategies to enhance clinical operations and to ensure an effective care delivery network, community care program, and a comprehensive ambulatory risk management program.

Additionally, Moore will be responsible for ensuring that UC San Diego Health System’s clinical programs and activities achieve the highest standards of service and are integrated to support the unique needs of an academic health system.

“I am extremely pleased that Dr. Moore will continue to contribute greatly to our organization’s mission of delivering outstanding patient care through commitment to the community, groundbreaking research and inspired teaching,” said Paul Viviano, CEO, UC San Diego Health System. “In this expanded role, he will also help to enhance the patient experience, streamline operational efficiencies and improve clinical outcomes.”

Previously, Moore was professor and chairman of the Department of Reproductive Medicine for 18 years and chair of the Women and Infants Clinical Program Council. He was also a member of the Health System’s Strategic Planning Steering Committee, the Medical Group’s Board of Governors Finance Committee and the Council of Chairs, and served as chair of the Jacobs Medical Center Birth Center Steering Committee. Moore has been with UC San Diego Health System since 1983.

Moore served 25 years in the U.S. Navy and participated in two executive development programs through the Wharton School of Business and the Harvard School of Business. During his medical training, he completed a fellowship in Maternal-Fetal Medicine at UC San Diego School of Medicine after completing his residency and internship in Obstetrics and Gynecology at the Naval Medical Center San Diego. Moore earned his medical degree and graduated cum laude from Yale University in Connecticut. He has authored and co-authored more than 150 peer-reviewed journal articles and chapters in major medical textbooks, including co-editing Creasy and Resnik’s Maternal Fetal Medicine and contributing to Neonatal-Perinatal Medicine and Diseases of the Newborn.

Nationally, Moore has served as officer and participant on numerous boards and advisory panels including those of the American Board of Obstetrics and Gynecology, American College of Obstetricians and Gynecologists, American Gynecological and Obstetrical Society, and National Institutes of Health. Moore has been ranked several times as one of the top obstetricians and gynecologists in the nation by U.S. News & World Report, and has been named repetitively as a “Top Doc” in San Diego Magazine’s “Physicians of Exceptional Excellence” annual survey performed in collaboration with the San Diego County Medical Society. Most recently he received the Louis M. Hellman MD Midwifery Partnership Award from the American College of Obstetricians and Gynecologists.

View original article

CATEGORY: NewsComments Off

New contract reached for residents at UCSF Benioff Children’s Hospital Oakland

Agreement benefits physicians and patients.

UCSF Benioff Children’s Hospital Oakland and the Committee of Interns and Residents (CIR/SEIU Healthcare) have announced a contract settlement that recognizes the importance of the 91 resident physicians to the hospital and their role in furthering the hospital’s goal of providing unsurpassed care to children throughout the Bay Area.

“UCSF Benioff Children’s Hospital Oakland values our mission of educating physicians-in-training to become the next generation of pediatric caregivers,” says Dr. Bertram Lubin, president and CEO of UCSF Benioff Children’s Hospital Oakland. “We are pleased to have reached an agreement that further enables our residents to become outstanding pediatricians and pediatric sub-specialists in our community.”

The Committee of Interns and Residents voted and approved the contract, which will be in effect until May 2016. The agreement doubles the educational allowance for resident physicians and provides an additional subsidy to help cover the cost of the Board Exams that residents must take in their final year of residency. The educational allowance, which residents use to pay for books, conferences and electronic devices, will be increased from $500, $550 and $600 for first, second and third year residents to $1,000, $1,100 and $1,200, respectively through May 2016. The contract also provides a $500 ratification bonus to all residents. At the same time, the agreement takes into consideration the hospital’s need to be fiscally responsible in this challenging health care environment.

The residents’ union and the hospital also agreed to reassign an existing fund operated by the CHO Foundation to be used as a Patient Care Fund. The fund, which currently contains $93,000, can be used to purchase discharge medications and equipment based on needs identified by the resident physicians.

“It has been a difficult journey, but my fellow co-workers and I have certainly gained an understanding of the bargaining process and the importance of standing together,” said Dr. Ana Liang, a third-year resident and member of the CIR bargaining committee. “With the ratification of this new contract, I hope we continue to build upon our strengths as a residency program and as an institution bringing world class care to the children of Oakland.”

Both sides said they are gratified with the results and are looking forward to collaborating on advocacy efforts to protect Alameda County’s safety net hospitals and to improve the health of the community.

Media contacts:
Melinda Krigel, UCSF Benioff Children’s Hospital Oakland
(510) 428-3069

Heather Appel, CIR/SEIU Healthcare
(917) 886-3651

View original article

CATEGORY: NewsComments Off

Chancellor highlights UCSF’s strengths in era of change

Sam Hawgood recognizes UCSF community in inaugural State of the University.

UCSF Chancellor Sam Hawgood shares a laugh with Andre Campbell and Elizabeth Ozer after delivering his inaugural State of the University address at UCSF today (Sept. 30).

UCSF is poised at “a key inflection point” in its history and must be prepared to swing in new directions, Chancellor Sam Hawgood, M.B.B.S., said in his inaugural State of the University speech.

Hawgood addressed a packed auditorium in Cole Hall today (Sept. 30). The audience included nearly 80 past chancellors award winners whom Hawgood recognized to much applause.

Hawgood lauded UCSF for its unwavering support of basic science, its dedication to cultivating the best education and patient care, and its many successes at merging biology and technology in ways that are revolutionizing health.

“To thrive, we will need to be receptive to change and willing to swing in new directions while remaining true to our essential values – no small challenge to get right,” he said.

Hawgood noted that as the university celebrates its 150th anniversary this year, it is “at a hinge of history.” To continue to excel, he said, the university must adapt to changing funding situations and a new era of health and education with advances of technology.

As a 32-year member of the UCSF family, Hawgood said he’s honored to lead UCSF into this next phase in history – marked by new ways of teaching in a digital world, closer ties with the community that surrounds UCSF, and unprecedented levels of teamwork in health care delivery.

“Today, UCSF is a $4.9 billion enterprise. Despite significant stresses for all our community during a recessionary period, this represents more than 50 percent growth in our operating budget over the last seven years,” Hawgood said.

UCSF’s endowment also reached an all-time high in 2014 but it still falls far short of peer private institutions. Hawgood said he will make growing this endowment a high priority.

Earlier this year, the National Institutes of Health funding report showed that UCSF was the top public recipient of competitive grants in 2013, with all four professional schools leading the nation in their respective fields. Hawgood noted this underscores the extraordinary faculty and is also a testament to the vision of previous chancellors, ”who saw the opportunity, measured the risk, and built the world-class facilities that enabled this growth.”

Despite UCSF’s banner growth, Hawgood noted that the university is facing a substantive and probably long-term change in funding streams.

Federal funding accounts for more than 40 percent of UCSF’s nearly $5 billion budget, yet federal funding for research has fallen 22 percent over the last decade. State funding has declined as well, and now represents less that 10 percent of the budget.

Hawgood said as the research and education funding shifts across the nation, “helping define and execute well new external partnerships and relationships across all our missions will be a priority of my chancellorship.” And these partnerships will help UCSF more directly translate new knowledge into human good, he said.

Hawgood mentioned several exciting new partnerships already under way, including UCSF’s work with Google to create an online platform to enable health workers around the world predict where malaria is likely to be transmitted. The project uses data from the Google Earth Engine and works to enable resource-poor countries to wage more targeted strategies against the mosquito-born disease, which kills 600,000 people a year.

UCSF is also capitalizing on the strength of the University of California through a new tri-institutional partnership among UC Berkeley, Lawrence Berkeley National Laboratory and UCSF, he said. “This new alliance will catalyze bold, potentially transformative and collaborative science and technology initiatives among the three partners, beginning with genomics, imaging, and super-computing.”

This year also saw a new clinical partnership as UCSF and the Children’s Hospital Oakland came together to create the UCSF Benioff Children’s Hospitals. This affiliation rivals the best children’s hospitals in the country and provides safety net services to some of the most underserved families in our community.

“These and other partnerships in place or in the planning stages, if done right, will help define UCSF’s distinctiveness and serve to help attract the brightest of faculty and students to our campus,” Hawgood said.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF appoints interim medical school dean

Bruce Wintroub, previously vice dean, has served UCSF for more than 32 years.

Bruce Wintroub, UC San Francisco

Bruce Wintroub, M.D., has been named interim dean of the UCSF School of Medicine while a search committee looks for a permanent replacement. Chancellor Sam Hawgood, M.B.B.S., made the announcement today (Sept. 11).

“I am deeply grateful to Bruce for his dedicated service and commitment to lead the School through this transition period,” said Hawgood, who served as dean of the School of Medicine until Wintroub’s appointment. “I am confident that he is well equipped to serve in this role and to ably steer the school through the months ahead.”

Wintroub has served UCSF for more than 32 years. Most recently he has served as vice dean of the School of Medicine, a position he held for 10 years. Wintroub is also a professor and has been chair of the Department of Dermatology since 1985.

“I am delighted, honored and privileged to serve in this capacity for the School of Medicine and UCSF,” he said. “I deeply appreciate the trust and confidence the chancellor has in me.”

Wintroub will maintain his responsibilities in the Department of Dermatology, including his position as chair.

He also has led the Dermatology Foundation, a nonprofit organization that develops and retains tomorrow’s teachers and researchers in dermatology. Wintroub has helped raise more than $60 million for the organization.

He earned a bachelor’s degree at Amherst College in Amherst, Massachusetts, and a medical degree at Washington University in St. Louis, Missouri. Wintroub completed residencies and fellowships at Peter Bent Brigham Hospital (internal medicine) and Harvard Medical School (immunology and dermatology) and was a member of the Harvard Medical School faculty for six years before joining UCSF in 1982.

A search committee, co-led by Catherine Lucey, M.D., vice dean for education in the School of Medicine, and Shaun Coughlin, M.D., Ph.D., director of the Cardiovascular Research Institute, has been charged to make recommendations to find a permanent School of Medicine dean.

View original article

CATEGORY: NewsComments Off

Innovation center names executive director

Karyn DiGiorgio to lead systemwide center.

Karyn DiGiorgio

Karyn DiGiorgio, M.S.N., R.N., has been appointed executive director of the UC Center for Health Quality and Innovation (CHQI).

The center, based at the UC Office of the President, is a systemwide effort launched in 2010 to support innovative grants and spread best practices that aim to improve quality, increase efficiencies and reduce costs at UC medical centers.

DiGiorgio joined UCOP in 2013 as the associate director of CHQI, after working for the Gordon and Betty Moore Foundation, where she was a program officer in the Betty Irene Moore Nursing Initiative.

“Karyn brings a wealth of experience to this position, having served as associate director since 2013,” said Dr. John Stobo, UC Health senior vice president. “Karyn also served as interim director since March of 2014 following the retirement of Terry Leach, and has helped to enhance the scope of the center’s mission, collaborating with UCOP and medical center leadership to develop and implement a variety of patient care and revenue models as well as systemwide reimbursement models that will support UC Health’s Leveraging Scale for Value initiative.”

UC Health launched its Leveraging Scale for Value initiative in March to collaborate as a system to reduce costs and enhance revenue at UC medical centers.

At the Moore Foundation, DiGiorgio developed and managed multiple systemwide health care grants in the Bay Area and greater Sacramento regions — many of which resulted in significant reductions in patient morbidity and mortality and led to improvements in patient care. Previously, she worked as the R.N. discharge coordinator and a staff/charge nurse in the emergency department at UCSF Medical Center. She is a graduate of Georgetown University and holds an M.S.N. in health policy from UC San Francisco and an M.S. from Drexel University in Philadelphia.

The Center for Health Quality and Innovation is governed by a board composed of the six UC medical school deans, five UC medical center CEOs and chaired by the UC Health senior vice president.

CATEGORY: NewsComments (1)

UCSF Medical Center, John Muir Health to collaborate

Affiliation would be cornerstone of regional network offering high-quality, affordable care.

UCSF Medical Center and John Muir Health have signed a letter of intent to develop a company that will serve as the cornerstone of a Bay Area health care network intended to provide patients with high-quality care and an exceptional experience at an affordable price. A final agreement is expected by the end of 2014.

Under the proposed agreement both organizations would remain independent, but a new company would be created that is equally owned and operated by both organizations. The new company would serve as a funding vehicle for future joint initiatives and a shared services organization to support programs and initiatives focused on better health care, at lower costs, for Bay Area patients.

The first of these joint initiatives is investment in a collaborative effort with other health care providers to form a regional health care network, or “accountable care organization” (ACO). Establishing a Bay Area-wide ACO will provide patients from throughout the Bay Area and Northern California with a competitively priced option to access, close to where they live or work, many of the Bay Area’s most trusted and respected hospitals, health systems and physician organizations.

Both John Muir Health and UCSF Medical Center have experience in successful ACOs that have demonstrated lower health care costs and improved health care quality. The goal of an ACO is to provide the right care at the right time and in the most appropriate setting, whether that is the primary care physician’s office, an outpatient center or a hospital, and savings achieved as part of an ACO can be passed along to consumers in the form of lower health care benefit premiums.

“By combining John Muir Health and UCSF’s strengths, we aim to offer patients the highest value system of care available,” said Mark R. Laret, CEO of UCSF Medical Center and UCSF Benioff Children’s Hospitals. “We look forward to working not just with each other, but with other health organizations throughout Northern California, in order to provide an exceptional health care experience for patients.”

“The jointly owned and operated company brings together two organizations that share a commitment to providing patients with high-quality care at an affordable price,” said Cal Knight, President and CEO of John Muir Health. “We looked at a number of affiliation options that would allow us to grow without compromising our mission, vision and independence. We found the right fit with UCSF and look forward to the development, along with other partners, of a regional ACO that will benefit patients and the communities we serve.”

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF names chair of bioengineering and therapeutic sciences

Tejal Desai’s appointment begins Aug. 1.

Tejal Desai, UC San Francisco

Tejal Desai, Ph.D., has been named the new chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department within the UC San Francisco School of Pharmacy and School of Medicine. Her appointment is effective Aug. 1.

“I am delighted Tejal will chair the Department of Bioengineering and Therapeutic Sciences,” said Chancellor Sam Hawgood, M.B.B.S., who is also serving as School of Medicine dean. “She has the vision, energy and experience that will ensure the department continues to thrive.”

“Tejal’s willingness to serve as department chair is characteristic of her collegial approach to science and education,” added School of Pharmacy Dean B. Joseph Guglielmo, Pharm.D. “She is an award-winning bioengineer and an accomplished teacher and administrator who has the deep respect of the faculty.  I’m very pleased Tejal has accepted the chair position.”

Desai replaces Kathy Giacomini, Ph.D., who stepped down to lead the UCSF-Stanford FDA Center of Excellence in Regulatory Science and Innovation (CERSI), a joint venture with Stanford University. The U.S. Food and Drug Administration (FDA) provided the funding for CERSI.

“Building upon her spectacular success with the creation of the Department of Bioengineering and Therapeutic Sciences with past co-chair Sarah Nelson, Ph.D., Kathy’s contributions to CERSI will be equally distinguished in the coming years,” Guglielmo said.

Prior to her appointment, Desai was vice chair in the Department of Bioengineering and Therapeutic Sciences.

“This is a unique department, not only at UCSF, but also internationally,” Desai said. “We have talented and diverse faculty members who aren’t afraid to take risks and work at the new intersection of pharmacy, medicine, engineering and basic science.  As chair, I hope to further strengthen the department, support and advocate for the faculty, and ensure the department’s continued success so it can be a model worldwide.”

Read more


CATEGORY: NewsComments Off

Regents confirm San Hawgood as UCSF chancellor

He is 10th chancellor of the health sciences campus.

UC President Janet Napolitano shakes the hand of the newly confirmed UCSF Chancellor Sam Hawgood at a press briefing after the Board of Regents approved his appointment on July 17. (Photo by Cindy Chew)

The University of California Board of Regents today (July 17) approved Sam Hawgood as the 10th chancellor of UC San Francisco, where he has served as dean of the UCSF School of Medicine and interim chancellor.

Hawgood, 61, was selected by President Janet Napolitano as the next chancellor after he rose to the top of a strong field of candidates. A search committee composed of regents, faculty, alumni, staff and students reviewed more than 375 candidates and interviewed seven finalists for the position.

“Dr. Hawgood’s list of accomplishments in the lab, in the clinic and in the administrative suite is long and illustrious,” said Regents Chairman Bruce D. Varner.

“Throughout a truly exhaustive selection process, Dr. Hawgood demonstrated the intellectual inquisitiveness, leadership acumen and powerful vision we seek in our chancellors,” Napolitano said. “When an exhaustive search lands on a candidate from within the institution, it is a sign that the enterprise is fundamentally robust. We have been fortunate to have Sam as a member of the UC family for more than 30 years.”

Hawgood had served as interim chancellor since Susan Desmond-Hellmann stepped down April 1, 2014, to become chief executive officer of the Bill & Melinda Gates Foundation.

UCSF, with an annual budget of $4.2 billion, includes nationally top-ranked graduate schools of medicine, dentistry, nursing and pharmacy, as well as affiliated hospitals, a pre-eminent biomedical research enterprise and a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences.

“I understand and deeply respect the core values of UCSF – and both the principle and practice of shared governance with the faculty,” Hawgood told the regents after they approved his appointment.

“But I know that, while we should remain connected to our past and preserve our values,” he said, “our times call for a rigorous look at the reality of the world today and a willingness to move forward in new directions. I embrace the opportunity to work closely with the faculty as we embark, together, on this journey.”

The Board of Regents approved a state-funded base salary of $500,000, plus $250,000 to be funded through an endowed chair, The Arthur Rock and Toni Rembe Distinguished Professorship, created specifically for the chancellor position by the UCSF Foundation, using no state funds.  His total cash compensation ranks 34th among chancellors and presidents of the 62 public research universities that are part of the Association of American Universities.

Consistent with past practice, Hawgood will receive an annual auto allowance of $8,916, and the university will provide him with the existing UCSF Chancellor’s home, which is suitable for duties such as fundraising. The residence is maintained with non-state funds.

With 22,800 faculty and staff, UCSF is the second-largest employer in San Francisco, and generates more than 17,000 additional jobs locally through its construction, its expenditures and purchases by employees, students and visitors.

Hawgood has served as dean of the UCSF School of Medicine and as vice chancellor for medical affairs since September 2009, after assuming the role of interim dean in December 2007. He previously had chaired the Department of Pediatrics, having first served in an interim role. He also served as associate director of the Cardiovascular Research Institute.

The School of Medicine has an operating budget of more than $1.9 billion, 7,400 faculty and staff, and about 3,655 medical and graduate students, residents, fellows and postdoctoral scholars. The school’s clinical faculty is known widely for world-class medical care through its practice in the top-ranked UCSF Medical Center, UCSF Benioff Children’s Hospital, San Francisco (newly affiliated with Children’s Hospital Oakland, now known as UCSF Benioff Children’s Hospital, Oakland), Langley Porter Psychiatric Institute, San Francisco General Hospital & Trauma Center, and the San Francisco Veterans’ Administration Medical Center.

Under Hawgood’s leadership, the school became the top medical school in the nation in research funding from the National Institutes of Health ($439.6 million in 2013), with many of its departments also leading the nation in their fields. It also became the only medical school in the nation to rank in the top five in both research and primary-care education, in the U.S. News & World Report’s annual assessment of graduate schools.

Numerous organizations and publications have recognized Hawgood’s scientific contributions. He is past president of the Society for Pediatric Research and a member of the American Association of Physicians, and in 2010 was elected to the Institute of Medicine (IOM), which provides authoritative advice to Congress, other decision makers and the public as part of the National Academy of Sciences. Membership in the IOM is one of the highest honors for individuals at the top of their fields.

“Curiosity-driven basic science is and will remain the jewel in the UCSF crown,” Hawgood said, “but two realities must be faced. The first is funding.  Federal funding in basic research and development is flat with declining purchasing power. I am committed to doing everything possible to strengthen basic research at UCSF.

“The second is the merging of technologic and biologic sciences in ways unimagined only a few years ago. Both these trends in the research sector suggest innovative public-public and public-private partnerships are needed as well as new routes to commercialization.”

UCSF research has led to revolutions in health and therapeutics, from the birth of the field of biotechnology and first therapies for HIV/AIDS to clinical innovations such as fetal surgery and stem cell therapies offering the promise of transforming lives worldwide. The faculty includes five Nobel laureates, who have made seminal contributions to advance the understanding of cancer, neurogenerative diseases, aging and stem cell research.

Hawgood has been active for decades in clinical medicine. He served as division chief of the Division of Neonatology, then as chair of Pediatrics and physician-in-chief of the UCSF Benioff Children’s Hospital before becoming dean. He has been serving as president of the UCSF Medical Group, the faculty association that represents more than 1,800 UCSF physicians.

He joined UCSF as a research fellow in 1982, working with distinguished scientists John A. Clements, M.D., and William H. Tooley, M.D., both pioneers in the discovery and therapeutic uses of pulmonary surfactant, the key lipoprotein that lines healthy lungs and enables them to expand with each breath. He has maintained his own laboratory since 1984. His research has gained him an international reputation in neonatology research.

A native of Australia, Hawgood entered medical school at the age of 17, and was graduated with First Class Honors from the University of Queensland in Brisbane with a degree in medicine and surgery (M.B.B.S.).

Hawgood and his wife, Jane, a social worker who recently retired after focusing on palliative care for adults, met at the University of Queensland. They have two grown sons.

Related link:
UCSF coverage

CATEGORY: NewsComments Off

UC Health appoints interim supply chain executive

UC Davis’ Vincent Johnson to lead systemwide supply chain efforts.

Vincent Johnson

The University of California has appointed Vincent Johnson, chief operating officer of UC Davis Medical Center, as interim UC Health systemwide supply chain executive.

For fiscal year 2015, Johnson will be responsible for the leadership and success of the joint UC medical centers’ systemwide procurement strategies and programs, as part of the “Leveraging Scale for Value” project to reduce costs at UC hospitals.

Advancing health care reform will require UC’s medical centers to operate more efficiently. UC medical centers recognize this challenge and have embarked upon an aggressive program to apply the integrated scale of UC to adapt to increasing resource and financial challenges.

UC’s Leveraging Scale for Value project, announced in March, initially will focus on three areas: supply chain, revenue cycle and clinical laboratories. This effort is governed by the UC Health Shared Services Management Council, which consists of the five UC medical center CEOs, three medical school deans, two chancellors, one regent, three external experts and is chaired by UC Health Senior Vice President John Stobo.

Increasing systemwide leverage in supply chain is among the first efforts launched by the council to rapidly reduce operating expenses through aggressive procurement savings. Focusing initially on non-medical supplies, purchased services and capital procurement, UC plans to find savings through increasingly coordinated procurement. Medical supply savings also will be sought out with appropriate clinical support.

Johnson will lead this effort and report directly to the council. He will be supported by UC San Francisco Medical Center Chief Operating Officer and Supply Chain Vice Chair Ken Jones and the UC medical centers’ supply chain leadership team. Their savings target for fiscal year 2015 will be in excess of $50 million.

To accomplish these savings, Johnson and his teams will focus on working directly with UC’s supply and service vendors to reduce expenses through systemwide procurement leverage, infrastructure development and operating efficiencies.

Future supply chain improvement efforts will advance UC’s competitiveness through transformative programs built upon these initial systemwide savings efforts.

Related links:

CATEGORY: NewsComments Off